abstract |
The present invention provides a kind of CAR recruit and its applications in oncotherapy.Specifically, the anti-tumor activity of modified cells can be significantly improved the invention discloses CAR and IL-15, and/or IL-15 receptor is expressed simultaneously in T cell or NK cell. |